ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635
ORIC Stock | USD 9.80 0.07 0.71% |
About 62% of Oric Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Oric Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Oric |
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 04, 2024 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company...
Read at globenewswire.com
Oric Pharmaceuticals Fundamental Analysis
We analyze Oric Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Oric Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Oric Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oric Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Oric Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Oric Pharmaceuticals Related Equities
PEPG | PepGen | 6.70 | ||||
SEER | Seer | 4.20 | ||||
ANTX | AN2 Therapeutics | 3.73 | ||||
PMVP | Pmv Pharmaceuticals | 2.52 | ||||
PHVS | Pharvaris | 2.03 | ||||
CGEM | Cullinan Oncology | 1.83 | ||||
MOLN | Molecular Partners | 0.53 | ||||
EWTX | Edgewise Therapeutics | 0.31 | ||||
MLYS | Mineralys Therapeutics, | 1.42 | ||||
IMRX | Immuneering Corp | 1.44 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
ELVN | Enliven Therapeutics | 2.13 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
CCCC | C4 Therapeutics | 4.34 | ||||
CELC | Celcuity LLC | 6.12 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Managers Screen money managers from public funds and ETFs managed around the world |